期刊
CELL REPORTS
卷 16, 期 1, 页码 120-132出版社
CELL PRESS
DOI: 10.1016/j.celrep.2016.05.085
关键词
-
类别
资金
- Cancer Initiative of North Carolina and Free to Breathe
- NIH [T32HL094296]
- European Research Council [FP7-IDEAS-ERC-StG-2010-260524-KRASHIMPE]
- U.S. Department of Veterans Affairs
- Vanderbilt-Ingram Cancer Center Spore
Although epithelial NF-kappa B signaling is important for lung carcinogenesis, NF-kappa B inhibitors are ineffective for cancer treatment. To explain this paradox, we studied mice with genetic deletion of IK kappa beta in myeloid cells and found enhanced tumorigenesis in Kras(G12D) and urethane models of lung cancer. Myeloid-specific inhibition of NF-kappa B augmented pro-IL-1 beta processing by cathepsin G in neutrophils, leading to increased IL-1 beta and enhanced epithelial cell proliferation. Combined treatment with bortezomib, a proteasome inhibitor that blocks NF-kappa B activation, and IL-1 receptor antagonist reduced tumor formation and growth in vivo. In lung cancer patients, plasma IL-1 beta levels correlated with poor prognosis, and IL-1 beta increased following bortezomib treatment. Together, our studies elucidate an important role for neutrophils and IL-1 beta in lung carcinogenesis and resistance to NF-kappa B inhibitors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据